Published in:
Open Access 01-12-2018 | Correction
Correction to: Emerging roles of Myc in stem cell biology and novel tumor therapies
Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2018
Login to get accessExcerpt
In the publication of this article [1] there are three errors. The author would like to apologize to all the readers and researchers who contributed to the related works. This has now been included in this correction.
1.
The error: The author categorically stated in abstract that “N-Myc-driven neuroendocrine tumors tend to highly express NEUROD1,” but there is a controversy as to whether or not neuroendocrine lung cancer cells highly express NEUROD1. Not a few researchers believe that there is no clear correlation between N-Myc and NEUROD1. ASCL1 and NEUROD1 are required for the survival and proliferation of SCLCs. Importantly, ASCL1 but not NEUROD1 directly regulates well-known SCLC-related oncogenes and is required for tumor formation in vivo of GEMMs.